Total Payments
$55,672
2024 Payments
$567.81
Companies
20
Transactions
113
Medicare Patients
1,376
Medicare Billing
$112,546
Payment Breakdown by Category
Other$47,840 (85.9%)
Consulting$4,614 (8.3%)
Food & Beverage$2,281 (4.1%)
Travel$724.92 (1.3%)
Education$212.49 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,490 | 23 | 81.7% |
| Consulting Fee | $4,614 | 4 | 8.3% |
| Food and Beverage | $2,281 | 63 | 4.1% |
| Honoraria | $2,000 | 1 | 3.6% |
| Travel and Lodging | $724.92 | 5 | 1.3% |
| Grant | $350.00 | 1 | 0.6% |
| Education | $212.49 | 16 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $20,223 | 45 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $16,867 | 20 | $0 (2024) |
| Daiichi Sankyo Inc. | $9,393 | 11 | $0 (2021) |
| Seagen Inc. | $2,870 | 3 | $0 (2020) |
| Athenex Pharmaceutical Division, LLC | $2,000 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $1,763 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $1,640 | 3 | $0 (2023) |
| Exelixis Inc. | $171.33 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $153.04 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $108.64 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $567.81 | 10 | AstraZeneca Pharmaceuticals LP ($371.19) |
| 2023 | $2,054 | 5 | AstraZeneca Pharmaceuticals LP ($1,961) |
| 2022 | $1,788 | 4 | Novartis Pharmaceuticals Corporation ($1,700) |
| 2021 | $8,472 | 20 | PFIZER INC. ($2,854) |
| 2020 | $14,709 | 22 | Daiichi Sankyo Inc. ($8,798) |
| 2019 | $13,337 | 22 | AstraZeneca Pharmaceuticals LP ($7,279) |
| 2018 | $11,798 | 26 | AstraZeneca Pharmaceuticals LP ($6,017) |
| 2017 | $2,947 | 4 | PFIZER INC. ($2,750) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/03/2024 | AstraZeneca Pharmaceuticals LP | — | Grant | Cash or cash equivalent | $350.00 | General |
| 09/10/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Oncology | ||||||
| 09/05/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $25.64 | General |
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Oncology | ||||||
| 07/03/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | Janssen Biotech, Inc. | TALVEY (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Oncology | ||||||
| 03/28/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Oncology | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: ONCOLOGY | ||||||
| 02/09/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: Oncology | ||||||
| 01/05/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Oncology | ||||||
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Oncology | ||||||
| 11/28/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $31.28 | General |
| 09/28/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Consulting Fee | Cash or cash equivalent | $1,942.50 | General |
| Category: Oncology | ||||||
| 09/09/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.87 | General |
| 05/11/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $39.39 | General |
| Category: Genetic Disease | ||||||
| 09/23/2022 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2022 | Exelixis Inc. | Cabometyx (Drug) | Education | In-kind items and services | $41.20 | General |
| Category: Oncology | ||||||
| 06/16/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Oncology | ||||||
| 03/26/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2021 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2021 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2021 | PFIZER INC. | IBRANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $138.75 | General |
| 08/30/2021 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2021 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $9.76 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 369 | 545 | $147,019 | $31,957 |
| 2022 | 5 | 399 | 551 | $152,645 | $34,064 |
| 2021 | 4 | 305 | 437 | $114,405 | $26,283 |
| 2020 | 5 | 303 | 436 | $111,119 | $20,242 |
Total Patients
1,376
Total Services
1,969
Medicare Billing
$112,546
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 196 | 301 | $64,113 | $13,204 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 70 | 115 | $36,110 | $8,346 | 23.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 28 | 28 | $16,828 | $3,845 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 56 | $11,928 | $2,540 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 23 | 23 | $11,132 | $2,459 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 22 | $6,908 | $1,563 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 178 | 275 | $58,575 | $12,245 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 56 | 80 | $25,120 | $5,893 | 23.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 35 | 35 | $21,035 | $5,150 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 87 | $18,531 | $3,936 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 26 | 26 | $12,584 | $2,661 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 32 | $10,048 | $2,313 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 16 | $6,752 | $1,866 | 27.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 155 | 248 | $52,824 | $11,813 | 22.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 49 | 74 | $23,236 | $5,706 | 24.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 61 | $12,993 | $2,855 | 22.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 18 | 18 | $10,818 | $2,522 | 23.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 19 | 19 | $9,196 | $2,096 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 17 | $5,338 | $1,292 | 24.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 149 | 245 | $52,185 | $8,896 | 17.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 37 | 57 | $17,898 | $3,496 | 19.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 24 | 24 | $11,616 | $2,426 | 20.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 63 | $13,419 | $2,314 | 17.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 14 | 14 | $8,414 | $1,799 | 21.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 18 | $5,652 | $1,035 | 18.3% |
About Dr. Kristina Bowen, MD
Dr. Kristina Bowen, MD is a Hematology & Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922086784.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristina Bowen, MD has received a total of $55,672 in payments from pharmaceutical and medical device companies, with $567.81 received in 2024. These payments were reported across 113 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,490).
As a Medicare-enrolled provider, Bowen has provided services to 1,376 Medicare beneficiaries, totaling 1,969 services with total Medicare billing of $112,546. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Atlanta, GA
- Active Since 01/03/2006
- Last Updated 08/26/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1922086784
Products in Payments
- IBRANCE (Drug) $20,223
- LYNPARZA (Drug) $13,208
- Enhertu (Drug) $9,353
- TUKYSA (Drug) $2,870
- ENHERTU (Biological) $1,943
- PIQRAY (Drug) $1,700
- Trodelvy (Drug) $1,605
- Cabometyx (Drug) $171.33
- OPDIVO (Biological) $153.04
- TAGRISSO (Drug) $127.70
- KEYTRUDA (Biological) $108.64
- DARZALEX (Biological) $62.27
- VERZENIO (Drug) $59.77
- MAVYRET (Drug) $39.87
- FABRAZYME (Biological) $39.39
- Aliqopa (Drug) $37.70
- KISQALI (Drug) $31.77
- EPKINLY (Drug) $27.90
- NERLYNX (Drug) $27.57
- TALVEY (Biological) $24.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Atlanta
Dr. Jonathon Cohen, M.d, M.D
Hematology & Oncology — Payments: $330,523
Hematology & Oncology $330,523
Dr. Ajay Nooka, M.d., M.p.h.,F.a.c.p, M.D., M.P.H.,F.A.C.P
Hematology & Oncology — Payments: $256,358
Hematology & Oncology $256,358
Dr. Rodolfo Bordoni, Md, MD
Hematology & Oncology — Payments: $240,507
Hematology & Oncology $240,507
Dr. Mehmet Bilen, M.d, M.D
Hematology & Oncology — Payments: $134,196
Hematology & Oncology $134,196
Olatunji Alese, M.d, M.D
Hematology & Oncology — Payments: $131,083
Hematology & Oncology $131,083
Dr. Carlos Franco, Md, MD
Hematology & Oncology — Payments: $115,439
Hematology & Oncology $115,439